DSM to Build Biopharmaceutical Facility in Australia

DSM Biologics says it has signed preliminary agreements to enter into a partnership with the governments of the state of Queensland, Australia and the Commonwealth of Australia to build and operate a mammalian biopharmaceutical manufacturing facility at Brisbane. The facility will be the first major mammalian contract manufacturing organization in Australia, DSM says. The governments of Queensland and the Commonwealth of Australia will provide the full financial funding for the facility which is part of Queensland’s 10-year biotechnology strategic plan. DSM...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers